Inspite of the outcome of your clinical trials, Purdue continued developing OxyContin being a twelve­-hour drug. It didn't test OxyContin at much more Repeated intervals.His choice intended that for the very first time, concerns about OxyContin's length would be aired at a trial. Sealed proof could be laid out in public for class-action attorneys,